Doxofylline

1,9-Dideoxyforskolin is a derivative of Forskolin which unlike the parent compound is incapable of activating adenylate cyclase. Forskolin-induced stimulation of adenylate cyclase and increased cAMP levels is employed to study the modulation of ion

Caudal related homeobox (Cdx) genes are known to modulate axial elongation and patterning in many vertebrate embryos. Cdx4 regulates the ontogenesis of placental labyrinth in mice.

General description The gene encoding HHIP (hedgehog interacting protein) is located on human chromosome 4 and encodes for a protein belonging to the hedgehog-interacting protein (HHIP) family. Immunogen Recombinant fragment corresponding to a

Runt-related transcription factor 2/acute myeloid leukemia 3 protein (RUNX2, AML-3) belongs to Runt DNA-binding domain transcription factor family. RUNX2 gene is mapped to human chromosome 6p21.

General description Doxofylline is a novel xanthine derivative comprising of dioxolone group. Application Doxofylline has been used as a phosphodiesterase (PDE) inhibitor to study its protective effects on lipopolysaccharides (LPS)-induced

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

Doxofylline is a xanthine bronchodilator known to impede phosphodiesterase activities. Doxofylline is an inhibitor of PDEA xanthine bronchodilator known to impede phosphodiesterase activities.

A methylxanthine bronchodilator that inhibits phosphodiesterase activity and, thus, increases cAMP demonstrates decreased affinity towards adenosine A1 and A2 receptors, does not interfere with calcium influx into cells, and does not antagonize the